Hiperemezis and Serotonin Elevated Serum Serotonin Levels in Hyperemesis
Relationship Between Elevated Serum Serotonin Levels in Symptomatic Patients With Hyperemezis
1 other identifier
observational
90
1 country
1
Brief Summary
Serotonin excretion was investigated in the nausea and vomiting associated with hiperemezis gravid arum.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Oct 2013
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2013
CompletedFirst Submitted
Initial submission to the registry
November 13, 2013
CompletedFirst Posted
Study publicly available on registry
November 19, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2014
CompletedNovember 19, 2013
November 1, 2013
4 months
November 13, 2013
November 18, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
serum serotonin levels in hiperemezis gravidarum
6-14week pregnancy
Secondary Outcomes (1)
ıs there any assosiation between serotonin levels and severity of symptoms in pregnant women with hiperemezis
6-14week pregnancy
Other Outcomes (1)
ıs there any assosiation between other serum parameters includes estrogen,progesterone and serum beta hcg
6-14week pregnancy
Eligibility Criteria
pregnant women between six and fourteen weeks
You may qualify if:
- week pregnant women
- nausea
- protracted vomiting
- inability to tolerate food intake accompanied by obvious dehydration
- severe enough to justify hospitalisation
- at least 2+ ketonuria on dipstick urinanalysis.
You may not qualify if:
- with metabolic disorders such as diabet, thyroid
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Bakirkoy Dr Sadi Konuk Training and Research Hospital
Istanbul, Istanbul, 34140, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
hüseyin cengiz, md
Bakırkoy Dr. Sadi Konuk Training and Research Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 13, 2013
First Posted
November 19, 2013
Study Start
October 1, 2013
Primary Completion
February 1, 2014
Study Completion
March 1, 2014
Last Updated
November 19, 2013
Record last verified: 2013-11